Cargando…
Correction to: Risk of dementia among postmenopausal breast cancer survivors treated with aromatase inhibitors versus tamoxifen: a cohort study using primary care data from the UK
Autores principales: | Bromley, Susan E., Matthews, Anthony, Smeeth, Liam, Stanway, Susannah, Bhaskaran, Krishnan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881411/ https://www.ncbi.nlm.nih.gov/pubmed/31641936 http://dx.doi.org/10.1007/s11764-019-00806-5 |
Ejemplares similares
-
Risk of dementia among postmenopausal breast cancer survivors treated with aromatase inhibitors versus tamoxifen: a cohort study using primary care data from the UK
por: Bromley, Susan E., et al.
Publicado: (2019) -
Endocrine therapy use and cardiovascular risk in postmenopausal breast cancer survivors
por: Matthews, Anthony A, et al.
Publicado: (2021) -
Statin use in cancer survivors versus the general population: cohort study using primary care data from the UK clinical practice research datalink
por: Chidwick, Kendal, et al.
Publicado: (2018) -
Long term adjuvant endocrine therapy and risk of cardiovascular disease in female breast cancer survivors: systematic review
por: Matthews, Anthony, et al.
Publicado: (2018) -
Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases
por: Strongman, Helen, et al.
Publicado: (2019)